William F. Boyer

1.3k total citations
27 papers, 1.0k citations indexed

About

William F. Boyer is a scholar working on Pharmacology, Psychiatry and Mental health and Experimental and Cognitive Psychology. According to data from OpenAlex, William F. Boyer has authored 27 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pharmacology, 16 papers in Psychiatry and Mental health and 6 papers in Experimental and Cognitive Psychology. Recurrent topics in William F. Boyer's work include Treatment of Major Depression (16 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (6 papers) and Electroconvulsive Therapy Studies (6 papers). William F. Boyer is often cited by papers focused on Treatment of Major Depression (16 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (6 papers) and Electroconvulsive Therapy Studies (6 papers). William F. Boyer collaborates with scholars based in United States, Colombia and Indonesia. William F. Boyer's co-authors include John P. Feighner, G. GORDON HENDRICKSON, C. Raymond Lake, Charles Merideth, Carl F. Doershuk, Thomas F. Boat, LeRoy W. Matthews, Dennis Drotar, Robert C. Stern and Joseph P. McEvoy and has published in prestigious journals such as PEDIATRICS, The British Journal of Psychiatry and Acta Psychiatrica Scandinavica.

In The Last Decade

William F. Boyer

27 papers receiving 933 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William F. Boyer United States 16 432 360 300 227 192 27 1.0k
R. Nil Switzerland 21 424 1.0× 295 0.8× 384 1.3× 136 0.6× 238 1.2× 47 1.2k
N Reisby Denmark 14 520 1.2× 483 1.3× 296 1.0× 190 0.8× 153 0.8× 27 1.1k
Jay B. Cohn United States 17 554 1.3× 481 1.3× 417 1.4× 151 0.7× 220 1.1× 30 1.2k
Joseph Mendels United States 21 533 1.2× 448 1.2× 373 1.2× 233 1.0× 230 1.2× 33 1.5k
Ram Shrivastava United States 16 554 1.3× 577 1.6× 443 1.5× 246 1.1× 172 0.9× 28 1.3k
J M Perel United States 21 331 0.8× 433 1.2× 263 0.9× 220 1.0× 450 2.3× 31 1.3k
P.M.J. Haffmans Netherlands 20 341 0.8× 455 1.3× 359 1.2× 178 0.8× 221 1.2× 44 1.2k
M. Lader United Kingdom 20 246 0.6× 405 1.1× 281 0.9× 192 0.8× 165 0.9× 39 1.1k
Charles S. Wilcox United States 16 320 0.7× 275 0.8× 272 0.9× 127 0.6× 171 0.9× 27 806
Ward T. Smith United States 13 419 1.0× 298 0.8× 412 1.4× 169 0.7× 203 1.1× 17 892

Countries citing papers authored by William F. Boyer

Since Specialization
Citations

This map shows the geographic impact of William F. Boyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William F. Boyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William F. Boyer more than expected).

Fields of papers citing papers by William F. Boyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William F. Boyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William F. Boyer. The network helps show where William F. Boyer may publish in the future.

Co-authorship network of co-authors of William F. Boyer

This figure shows the co-authorship network connecting the top 25 collaborators of William F. Boyer. A scholar is included among the top collaborators of William F. Boyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William F. Boyer. William F. Boyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Feighner, John P. & William F. Boyer. (1996). Selective serotonin re-uptake inhibitors : advances in basic research and clinical practice. 48 indexed citations
2.
Boyer, William F.. (1995). Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks. International Clinical Psychopharmacology. 10(1). 45–50. 129 indexed citations
3.
Boyer, William F. & John P. Feighner. (1994). Clinical significance of early non‐response in depressed patients. 2(1). 32–35. 6 indexed citations
4.
Boyer, William F., et al.. (1993). A placebo-controlled double-blind multicenter trial of two doses of ipsapirone versus diazepam in generalized anxiety disorder. International Clinical Psychopharmacology. 8(3). 173–176. 24 indexed citations
5.
Boyer, William F.. (1992). Potential Indications for the Selective Serotonin Reuptake Inhibitors. International Clinical Psychopharmacology. 6. 5–12. 38 indexed citations
6.
Boyer, William F. & John P. Feighner. (1992). An overview of paroxetine.. PubMed. 53 Suppl. 3–6. 36 indexed citations
7.
Feighner, John P. & William F. Boyer. (1991). The diagnosis of depression. Wiley eBooks. 4 indexed citations
8.
Feighner, John P. & William F. Boyer. (1991). Selective Serotonin Re-Uptake Inhibitors: The Clinical Use of Citalopram, Fluoxetine, Fluvoxamine, Paroxetine, and Sertraline. Medical Entomology and Zoology. 20 indexed citations
9.
Feighner, John P. & William F. Boyer. (1991). Selective Serotonin Re-uptake Inhibitors. International Clinical Psychopharmacology. 6(2). 126–126. 95 indexed citations
10.
Feighner, John P., et al.. (1990). A Controlled Trial of Adinazolam versus Desipramine in Geriatric Depression. International Clinical Psychopharmacology. 5(3). 227–232. 12 indexed citations
11.
Feighner, John P. & William F. Boyer. (1989). Serotonin-IA Anxiolytics: An Overview. Psychopathology. 22(1). 21–26. 103 indexed citations
12.
Feighner, John P., et al.. (1989). A Placebo-controlled Inpatient Comparison of Fluvoxamine Maleate and Imipramine in Major Depression. International Clinical Psychopharmacology. 4(3). 239–244. 66 indexed citations
13.
Feighner, John P. & William F. Boyer. (1989). Paroxetine in the treatment of depression: a comparison with imipramine and placebo. Acta Psychiatrica Scandinavica. 80(S350). 125–129. 56 indexed citations
14.
Feighner, John P., William F. Boyer, Charles Merideth, & G. GORDON HENDRICKSON. (1989). A Double-Blind Comparison of Fluoxetine, Imipramine and Placebo in Outpatients with Major Depression. International Clinical Psychopharmacology. 4(2). 127–134. 47 indexed citations
15.
Boyer, William F. & John P. Feighner. (1989). An overview of fluoxetine, a new serotonin-specific antidepressant.. PubMed. 56(2). 136–40. 14 indexed citations
16.
Boyer, William F., et al.. (1988). An Overview of Fluoxetine in Geriatric Depression. The British Journal of Psychiatry. 153(S3). 105–108. 37 indexed citations
17.
Boyer, William F., et al.. (1987). Anticholinergic Prophylaxis of Acute Haloperidol-Induced Acute Dystonic Reactions. Journal of Clinical Psychopharmacology. 7(3). 164???166–164???166. 37 indexed citations
18.
Lake, C R, et al.. (1986). Anticholinergic prophylaxis in young adults treated with neuroleptic drugs.. PubMed. 22(3). 981–4. 10 indexed citations
19.
Drotar, Dennis, Carl F. Doershuk, Robert C. Stern, et al.. (1981). Psychosocial Functioning of Children with Cystic Fibrosis. PEDIATRICS. 67(3). 338–343. 66 indexed citations
20.
Bolívar, Francisco, et al.. (1978). A general methodforthepurification ofrestriction enzymes. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026